Ken Griffin Global Cord Blood Corp Call Options Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
SELL
$2.99 - $2.99 $4,784 - $4,784
-1,600 Reduced 20.78%
6,100 $18,000
Q4 2022

Feb 14, 2023
SELL
$2.99 - $2.99 $15,249 - $15,249
-5,100 Reduced 39.84%
7,700 $23,000
Q3 2022

Nov 14, 2022
BUY
$2.05 - $3.0 $1,434 - $2,100
700 Added 5.79%
12,800 $38,000

Others Institutions Holding CO

# of Institutions
2
Shares Held
52.9K
Call Options Held
0
Put Options Held
0
View Full List

About Global Cord Blood Corp

CO Quotes by TradingView
  • Ticker CO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 133,915,000
  • Description
  • Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matchin...
More about CO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email